The Economics of Sepsis

被引：72

作者：

Chalupka, Andrew N.

Talmor, Daniel ^{[1
,2
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA

来源：

CRITICAL CARE CLINICS | 2012年 / 28卷 / 01期

关键词：

Sepsis; Bloodstream infection; Economics; Costs; Cost-effectiveness; INTENSIVE-CARE UNITS; ACTIVATED PROTEIN-C; BLOOD-STREAM INFECTION; HOSPITAL-ACQUIRED BACTEREMIA; CENTRAL VENOUS CATHETERS; COST-EFFECTIVENESS; METHICILLIN-RESISTANT; NOSOCOMIAL INFECTIONS; ATTRIBUTABLE COST; SURVIVING SEPSIS;

D O I：

10.1016/j.ccc.2011.09.003

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Sepsis, severe sepsis, and septic shock impose a growing economic burden on health care systems globally. This article first describes the epidemiology of sepsis within the United States and internationally. It then reviews costs associated with sepsis and its management in the United States and internationally, including general cost sources in intensive care, direct costs of sepsis, and indirect costs of the burden of illness imposed by sepsis. Finally, it examines the cost-effectiveness of sepsis interventions, focusing on formal cost-effectiveness analyses of nosocomial sepsis prevention strategies, drotrecogin alfa (activated), and integrated sepsis protocols.

引用

收藏

页码：57 / +

页数：21

相关论文

共 100 条

[51] The Relationship Between Hospital Spending and Mortality in Patients With Sepsis [J].

Lagu, Tara ;

Rothberg, Michael B. ;

Nathanson, Brian H. ;

Pekow, Penelope S. ;

Steingrub, Jay S. ;

Lindenauer, Peter K. .

ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (04) :292-299

[52] Detailed cost analysis of care for survivors of severe sepsis [J].

Lee, H ;

Doig, CJ ;

Ghali, WA ;

Donaldson, C ;

Johnson, D ;

Manns, B .

CRITICAL CARE MEDICINE, 2004, 32 (04) :981-985

[53] Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections [J].

Lee, Ingi ;

Morales, Knashawn H. ;

Zaoutis, Theoklis E. ;

Fishman, Neil O. ;

Nachamkin, Irving ;

Lautenbach, Ebbing .

AMERICAN JOURNAL OF INFECTION CONTROL, 2010, 38 (09) :740-745

[54] Patient characteristics and costs of severe sepsis and septic shock in Quebec [J].

Letarte, J ;

Longo, CJ ;

Pelletier, J ;

Nabonne, B ;

Fisher, HN .

JOURNAL OF CRITICAL CARE, 2002, 17 (01) :39-49

[55] Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia [J].

Lodise, TP ;

McKinnon, PS .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (02) :113-122

[56] An economic evaluation of activated protein C treatment for severe sepsis. [J].

Manns, BJ ;

Lee, H ;

Doig, CJ ;

Johnson, D ;

Donaldson, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :993-1000

[57] The effect of age on the development and outcome of adult sepsis [J].

Martin, GS ;

Mannino, DM ;

Moss, M .

CRITICAL CARE MEDICINE, 2006, 34 (01) :15-21

[58] The epidemiology of sepsis in the United States from 1979 through 2000 [J].

Martin, GS ;

Mannino, DM ;

Eaton, S ;

Moss, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (16) :1546-1554

[59] Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections [J].

McHugh, CG ;

Riley, LW .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (05) :425-430

[60] Determining the economic cost of ICU treatment: a prospective "micro-costing" study [J].

McLaughlin, Anne Marie ;

Hardt, Judy ;

Canavan, James B. ;

Donnelly, Maria B. .

INTENSIVE CARE MEDICINE, 2009, 35 (12) :2135-2140

← 1 2 3 4 5 6 7 8 9 10 →